Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Hair elemental analysis could be useful for health and exposure assessment but requires more standardization and research.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Autistic children have lower iron and higher selenium in their hair.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

Iron therapy resolved uncooked rice cravings and symptoms in women with iron deficiency.

Human hair's biomagnetic fields can affect blood cell clumping and coagulation.

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.